Evidence map›Paper›PMID 42675229›Full record

ArticleDigestive diseases and sciences2026

Hepatology-Led Education on Alcohol-Related Liver Disease During Chemical Dependency Treatment: Impact on Return to Drinking.

Taylor Bowler, Lisa Vollmer, Alexander Hubbell, Elizabeth S Aby, Mary Thomson

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Taylor BowlerDepartment of Internal Medicine, University of Minnesota, Minneapolis, MN, USA, 55455.
Lisa VollmerDepartment of Family Medicine and Community Health, University of Minnesota, Minneapolis, MN, USA.
Alexander HubbellDepartment of Family Medicine and Community Health, University of Minnesota, Minneapolis, MN, USA.
Elizabeth S AbyDivision of Gastroenterology, Hepatology and Nutrition, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN, 55455, USA.
Mary ThomsonDivision of Gastroenterology, Hepatology and Nutrition, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN, 55455, USA. thoms482@umn.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInpatient chemical dependency programs for alcohol use disorder (AUD) primarily focus on treating the use disorder, with limited attention to alcohol-related medical complications. We implemented a hepatology provider-led educational intervention focused on alcohol-related liver disease (ARLD) within an inpatient alcohol treatment program and evaluated the intervention's impact on return to alcohol use and subsequent healthcare utilization.

methodsData were collected between 1/2023 and 12/2024. Patients were categorized into historical and educational groups based on admission before or after implementation of the intervention. Data on return to alcohol use were collected through manual chart review. Demographics, ICD codes for AUD/ARLD, laboratory values, AUD medication use, return to alcohol and subsequent AUD/ARLD healthcare utilization, and mortality were also evaluated. Patients completed a voluntary survey asking for feedback regarding this intervention. Bivariate analyses assessed associations between patient characteristics and clinical outcomes. Kaplan-Meier methods estimated alcohol-free survival, and Cox proportional hazards regression estimated adjusted hazard ratios (HRs) for return to alcohol use.

results465 patients (n=233 historical, n=232 educational) were included. Most patients were white (71.6%) males (65.4%) with a mean age of 40.2 ± 11.7 years. 38.9% of patients returned to alcohol use after treatment. The education intervention was associated with improved alcohol-free survival at one year (HR 0.67, 95%CI 0.50-0.93, p=0.016). Patients in the educational cohort had a higher frequency of healthcare encounters for compensated ARLD after treatment than those in the historical cohort (19.0% vs. 12.0%, p=0.041), primarily due to an increase in outpatient visits. Of those who completed surveys, 85.6% were interested in the topic, 83.1% believed it was helpful in maintaining sobriety, and 74.7% believed that they were more likely to follow-up with a provider to discuss their ARLD.

conclusionIntegrating a hepatology provider-led educational session into AUD treatment was associated with reduced return to drinking at one year. Individuals in the educational group may have been more empowered to seek medical evaluation and follow-up for liver disease after completing treatment. This intervention is scalable with potential to improve treatment of ALRD.

Indexed as

Alcohol-related liver diseaseAlcohol use disorderChemical dependency

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.